May 6, 2021 -- Bio-Techne reported strong growth in revenues for its third quarter (end-March 31), thanks largely to sales in its protein analysis business.
For the third quarter, Bio-Techne posted revenue of $243.6 million, up 22% compared to last year, with foreign currency exchange having a favorable effect of 3%.
For the first nine months of fiscal year 2021, the company reported revenue of $672 million, up 17% compared to last year.
Additionally, the company reported net sales of its protein sciences segment, which provides an array of platforms useful in various areas of protein analysis, were $185.6 million, a record increase of 28% from $145.5 million for the third quarter of fiscal 2020, according to a release.
Copyright © 2021 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
